Primary small cell carcinoma of the pancreas: Rare type of pancreatic cancer and review of the literatures

17Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Back ground: Primary small cell carcinoma of the pancreas (SCCP) is a rare malignancy with an extremely poor prognosis which accounts for 1 to 1.4 percent of all pancreatic malignancies.Case presentation: We present the case of a 62-year-old man with a half-month history of upper abdominal discomfort who was diagnosed with SCC of the pancreatic tail. A Chest X-ray showed no evidence of primary lung tumor. The diagnosis of a SCCP was confirmed by post-surgery pathology and immunohistology. In our review of the published reports of SCCP, we only found a few cases reported in the literatures. The diagnosis of SCCP needs the post-surgery pathology and immunohistology and the prognosis of SCCP is extremely poor. There was a significant increase in median survival, from 1 to 6 months, in treated patients compared to patients treated only by symptomatic management. Chemotherapy was the most common treatment and the combination of cisplatin/etoposide was most frequently prescribed.Conclusion: The accurate diagnosis of (SCCP) is necessary for determining prognosis and deciding appropriate therapy. © 2012 Wang et al; licensee BioMed Central Ltd.

Cite

CITATION STYLE

APA

Wang, D., Rong, Y., Wu, W., & Jin, D. (2012). Primary small cell carcinoma of the pancreas: Rare type of pancreatic cancer and review of the literatures. World Journal of Surgical Oncology, 10. https://doi.org/10.1186/1477-7819-10-32

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free